Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Oberlin

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control studySylvie Guérin, Mike Hawkins, Akhtar Shamsaldin, et al.
Journal of Pediatric Surgery|January 23, 2009
Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experienceHélène Martelli, Christine Haie-Meder, Sophie Branchereau, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fieldsFrance Nguyen, Carole Rubino, Sylvie Guerin, et al.
Head & Neck|June 20, 2006
Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasmsPierre Olivier Védrine, Laurent Coffinet, Stéphane Temam, et al.
Sarcoma|March 28, 2013
Erratum to "desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literature"Caroline Oudot, Daniel Orbach, Véronique Minard-Colin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric OncologyRichard J Stewart, Hélène Martelli, Odile Oberlin, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
Sarcoma|August 28, 2012
Desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literatureCaroline Oudot, Daniel Orbach, Véronique Minard-Colin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Infantile fibrosarcoma: management based on the European experienceDaniel Orbach, Annie Rey, Giovanni Cecchetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groupsOdile Oberlin, Annie Rey, Elizabeth Lyden, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control studySylvie Guérin, Mike Hawkins, Akhtar Shamsaldin, et al.
Journal of Pediatric Surgery|January 23, 2009
Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experienceHélène Martelli, Christine Haie-Meder, Sophie Branchereau, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fieldsFrance Nguyen, Carole Rubino, Sylvie Guerin, et al.
Head & Neck|June 20, 2006
Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasmsPierre Olivier Védrine, Laurent Coffinet, Stéphane Temam, et al.
Sarcoma|March 28, 2013
Erratum to "desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literature"Caroline Oudot, Daniel Orbach, Véronique Minard-Colin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric OncologyRichard J Stewart, Hélène Martelli, Odile Oberlin, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
Sarcoma|August 28, 2012
Desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literatureCaroline Oudot, Daniel Orbach, Véronique Minard-Colin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Infantile fibrosarcoma: management based on the European experienceDaniel Orbach, Annie Rey, Giovanni Cecchetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groupsOdile Oberlin, Annie Rey, Elizabeth Lyden, et al.
Pageof 12